Trial Profile
STUDY OF PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP- TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA AND 2 OR MORE RISK FACTORS FOR CORONARY HEART DISEASE.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Simvastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Kowa Pharmaceutical
- 25 Aug 2011 Week 44 results published in the Advances in Therapy.
- 25 Aug 2011 Primary non-inferiority endpoint 'LDL-cholesterol-level' has been met (3060484), according to results published in Advances in Therapy.
- 25 Aug 2011 Results published in the Advances in Therapy.